UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer

European journal of cancer (1990), 2014-10, Vol.50 (15), p.2592-2601

2014

Volltextzugriff (PDF)

Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia

Supportive care in cancer, 2016-06, Vol.24 (6), p.2735-2741

2016

Volltextzugriff (PDF)

Reduced risk of distant recurrence after adjuvant chemotherapy in patients with stage III colon cancer aged 75 years or older

Annals of oncology, 2013-11, Vol.24 (11), p.2839-2844

2013

Volltextzugriff (PDF)

The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study

Gynecologic oncology, 2005-04, Vol.97 (1), p.104-109

2005

Volltextzugriff (PDF)

Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients

Journal of clinical oncology, 1998-09, Vol.16 (9), p.2921-2929

1998

Volltextzugriff (PDF)

The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2562-2569

2015

Volltextzugriff (PDF)

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2579-2588

1997

Volltextzugriff (PDF)

Duodenal metastasis: an uncommon cause of occult small intestinal bleeding

Netherlands journal of medicine, 2004-06, Vol.62 (6), p.201-205

2004

Volltextzugriff (PDF)

Assessing health-state utility values in patients with metastatic colorectal cancer: a utility study in the United Kingdom and the Netherlands

International journal of colorectal disease, 2014-10, Vol.29 (10), p.1203-1210

2014

Volltextzugriff (PDF)

Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody

JNCI : Journal of the National Cancer Institute, 1995-10, Vol.87 (19), p.1463-1469

1995

Volltextzugriff (PDF)

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study

British journal of cancer, 1995-11, Vol.72 (5), p.1283-1288

1995

Volltextzugriff (PDF)

Immunotherapy of metastatic renal cell cancer

Annals of oncology, 1996-11, Vol.7 (9), p.887-900

1996

Volltextzugriff (PDF)

A woman with haemolytic anaemia

Netherlands journal of medicine, 2006-07, Vol.64 (7), p.259, 261-261

2006

Volltextzugriff (PDF)

Weekly high-dose cisplatin in malignant pleural mesothelioma

Annals of oncology, 1994-04, Vol.5 (4), p.373-374

1994

Volltextzugriff (PDF)

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma

British journal of cancer, 1996-09, Vol.74 (6), p.951-955

1996

Volltextzugriff (PDF)

Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study

International journal of cancer, 1992, Vol.7 (sup. 7), p.78-81

1992

Volltextzugriff (PDF)

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma

Annals of oncology, 1995-07, Vol.6 (6), p.613-616

1995

Volltextzugriff (PDF)

Cardiotoxicity as a dose‐limiting factor in a schedule of high dose bolus therapy with interleukin‐2 and alpha‐interferon. An unexpectedly frequent complication

Cancer, 1994-11, Vol.74 (10), p.2850-2856

1994

Volltextzugriff (PDF)

Final report of a phase II study of interleukin 2 and interferon α in patients with metastatic melanoma

British journal of cancer, 1995-06, Vol.71 (6), p.1319-1321

1995

Volltextzugriff (PDF)

Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response

Journal of clinical oncology, 1993-05, Vol.11 (5), p.921-924

1993

Volltextzugriff (PDF)

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma

European journal of cancer (1990), 1996-10, Vol.32 (11), p.2026-2028

1996

Volltextzugriff (PDF)

Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer

British journal of cancer, 1996-12, Vol.74 (12), p.2018-2023

1996

Volltextzugriff (PDF)

Tunnelled central venous catheters yield a low incidence of septicaemia in interleukin-2-treated patients

Cancer Immunology, Immunotherapy, 1997-07, Vol.44 (5), p.301-304

1997

Volltextzugriff (PDF)

High-dose regimen of interleukin-2 and interferon-alpha in combination with lymphokine-activated killer cells in patients with metastatic renal cell cancer

Journal of immunotherapy (1997), 1997-07, Vol.20 (4), p.312-320

1997

Volltextzugriff (PDF)

Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancer

Journal of immunotherapy, 1992-07, Vol.12 (1), p.70-73

1992

Volltextzugriff (PDF)

1 – 25 von 355

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(332)
Mit Volltextzugriff
(313)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(283)
Technology
(198)
Engineering
(172)
Physical Sciences
(171)
Energy & Fuels
(136)
Thermodynamics
(134)
Engineering, Chemical
(128)
Exact Sciences And Technology
(105)
Applied Sciences
(93)
Engineering, Mechanical
(91)
Energy
(87)
Energy. Thermal Use Of Fuels
(83)
Life Sciences & Biomedicine
(80)
Engineering, Multidisciplinary
(72)
Humans
(72)
Theoretical Studies. Data And Constants. Metering
(64)
Combustion. Flame
(63)
Female
(52)
Combustion
(48)
Male
(47)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer

Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia

Reduced risk of distant recurrence after adjuvant chemotherapy in patients with stage III colon cancer aged 75 years or older

The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study

Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients

The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group

Duodenal metastasis: an uncommon cause of occult small intestinal bleeding

Assessing health-state utility values in patients with metastatic colorectal cancer: a utility study in the United Kingdom and the Netherlands

Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study

Immunotherapy of metastatic renal cell cancer

A woman with haemolytic anaemia

Weekly high-dose cisplatin in malignant pleural mesothelioma

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma

Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma

Cardiotoxicity as a dose‐limiting factor in a schedule of high dose bolus therapy with interleukin‐2 and alpha‐interferon. An unexpectedly frequent complication

Final report of a phase II study of interleukin 2 and interferon α in patients with metastatic melanoma

Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma

Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer

Tunnelled central venous catheters yield a low incidence of septicaemia in interleukin-2-treated patients

High-dose regimen of interleukin-2 and interferon-alpha in combination with lymphokine-activated killer cells in patients with metastatic renal cell cancer

Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancer

Suchergebnisse filtern